- Side Effects
- Dosing Schedule
- Drug Interactions
- Pregnancy and Nursing
What is the Pfizer-BioNTech COVID-19 vaccine?
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Pfizer-BioNTech COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 16 years of age and older.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the novel coronavirus, SARS-CoV-2, that appeared in late 2019. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have reported a wide range of symptoms, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.
The modRNA in the Pfizer-BioNTech COVID-19 Vaccine is formulated in lipid particles, which enable delivery of the RNA into host cells to allow expression of the SARS-CoV-2 S antigen. The vaccine elicits an immune response to the S antigen, which protects against COVID-19.
What are the side effects of the Pfizer-BioNTech COVID 19 Vaccine?
Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of Pfizer-BioNTech COVID-19 Vaccine.
Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine.
Pfizer-BioNTech COVID-19 Vaccine may not protect all vaccine recipients.
Adverse reactions following the Pfizer-BioNTech COVID-19 Vaccine that have been reported in clinical trials include injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, malaise, and lymphadenopathy.
Severe allergic reactions have been reported following the Pfizer-BioNTech COVID-19 Vaccine during mass vaccination outside of clinical trials. Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.
Do not administer Pfizer-BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer-BioNTech COVID-19 Vaccine
Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report all vaccine administration errors, all serious adverse events, cases of Multisystem Inflammatory Syndrome (MIS) in adults and children, and cases of COVID-19 that result in hospitalization or death following administration of Pfizer-BioNTech COVID-19 Vaccine.
What is the dosage for the Pfizer-BioNTech COVID-19 Vaccine?
The Pfizer-BioNTech COVID-19 Vaccine is a suspension for intramuscular injection administered as a series of two doses (0.3 mL each) 3 weeks apart.
Storage and Handling
During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light.
Do not refreeze thawed vials.
Frozen Vials Prior to Use
Cartons of Pfizer-BioNTech COVID-19 Vaccine Multiple Dose Vials arrive in thermal containers with dry ice. Once received, remove the vial cartons immediately from the thermal container and store in an ultra-low temperature freezer between -80°C to -60°C (-112°F to -76°F). Vials must be kept frozen between -80°C to -60°C (-112°F to -76°F) and protected from light until ready to use. If an ultra-low temperature freezer is not available, the thermal container in which the Pfizer-BioNTech COVID-19 Vaccine arrives may be used as temporary storage when consistently re-filled to the top of the container with dry ice. Refer to the re-icing guidelines packed in the original thermal container for instructions regarding the use of the thermal container for temporary storage. The thermal container maintains a temperature range of -90°C to -60°C (-130°F to -76°F). Storage within this temperature range is not considered an excursion from the recommended storage condition.
Thawed Vials Before Dilution
Thawed Under Refrigeration
Thaw and then store undiluted vials in the refrigerator [2°C to 8°C (35°F to 46°F)] for up to 5 days (120 hours). A carton of 25 vials or 195 vials may take up to 2 or 3 hours, respectively, to thaw in the refrigerator, whereas a fewer number of vials will thaw in less time.
Thawed at Room Temperature
For immediate use, thaw undiluted vials at room temperature [up to 25°C (77°F)] for 30 minutes. Thawed vials can be handled in room light conditions. Vials must reach room temperature before dilution.
Undiluted vials may be stored at room temperature for no more than 2 hours. After dilution, store vials between 2°C to 25°C (35°F to 77°F) and use within 6 hours from the time of dilution.
- During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light.
- Any vaccine remaining in vials must be discarded after 6 hours.
- Do not refreeze.
Dosing and Schedule
The Pfizer-BioNTech COVID-19 Vaccine is administered intramuscularly as a series of two doses (0.3 mL each) 3 weeks apart.
There are no data available on the interchangeability of the Pfizer-BioNTech COVID-19 Vaccine with other COVID-19 vaccines to complete the vaccination series. Individuals who have received one dose of Pfizer-BioNTech COVID-19 Vaccine should receive a second dose of Pfizer-BioNTech COVID-19 Vaccine to complete the vaccination series.
What drugs interact with the Pfizer-BioNTech COVID-19 Vaccine?
There is no information on the co-administration of the Pfizer-BioNTech COVID-19 Vaccine with other vaccines.
Is the Pfizer-BioNTech COVID-19 Vaccine safe to use while pregnant or breastfeeding?
Available data on Pfizer-BioNTech COVID-19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.
All pregnancies have a risk of birth defect, loss, or other adverse outcomes. In the US general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20% , respectively.
Data are not available to assess the effects of Pfizer-BioNTech COVID-19 Vaccine on the breastfed infant or on milk production/excretion.
- Most Injection Drug Users Are Not Seeking Out Fentanyl: Study
- Cancer Survivors Who Keep Smoking Have Double the Risk for Heart-Related Death
- Canada to Become 1st Country to Mandate Warning Labels on Individual Cigarettes
- Nova Scotia Wildfires Sending Unhealthy 'Smoke Plume' to U.S. Northeast
- U.S. Teen Birth Rate Hits Another Historic Low
- More Health News »
The Pfizer-BioNTech COVID 19 vaccine uses RNA -- a type of genetic coding molecule -- to get the body to produce its own copies of a certain coronavirus protein. Harmless by themselves, the protein molecules spur the immune system to develop antibodies. These antibodies protect you against COVID-19 (or at least, the most severe symptoms). The vaccine is not approved, but authorized for emergency use to combat the coronavirus pandemic.
Multimedia: Slideshows, Images & Quizzes
Rosacea, Acne, Shingles, Covid-19 Rashes: Common Adult Skin Diseases
Learn to spot and treat skin conditions commonly found in adults such as acne, Covid-19 rashes, eczema, shingles, psoriasis,...
Coronavirus: How COVID-19 Affects Your Body
By now, everyone knows about COVID-19. But do you know how it can affect your body?
COVID-19 Vaccine Myths and Facts Quiz
The FDA has granted Emergency Use Authorizations for COVID-19 vaccines that have been shown to be safe and effective as...
Novel Coronavirus (COVID-19) Prevention Quiz
Why is coronavirus considered dangerous? What are the symptoms you should look for? Take this COVID-19 prevention quiz to learn...
Coronavirus COVID-19 Prevention: Test Your Medical IQ
What's really the best way to prevent the spread of new coronavirus COVID-19? Should wear a mask or not? Take this quiz to find...
COVID-19 Coronavirus Disease: Articles of Interest
Read about COVID-19 Coronavirus Disease. See interesting articles related to vitamins and supplements to boost immunity,...
Coronavirus COVID-19 (SARS-CoV-2) Pandemic Outbreak: What You Need to Know
A new strain of coronavirus (COVID-19, SARS-CoV-2) was reported from Wuhan, China in December, 2019. This outbreak of respiratory...
Lung Disease & Respiratory Health: Should I Get a COVID-19 Antibody Test?
If you had COVID-19 symptoms but never got tested, or if you have long-term symptoms that just won't go away, you may want to get...
What Drugs May Fight COVID-19? Drug Trials, Treatments, Vaccines
What drugs could help fight coronavirus COVID-19? Clinical studies are ongoing for antiviral drugs like hydroxychloroquine,...
Related Disease Conditions
Is COVID-19 One of the Causes of Pleurisy?
Pleurisy is a painful lung condition that makes it hard to breathe. Learn what causes it, how it's diagnosed, what you can do to treat it, and if COVID-19 causes it.
COVID-19 vs. Flu vs. Cold
When you're feeling sick, it can be difficult to distinguish the symptoms of a COVID-19 infection from the symptoms of the common cold or the flu (influenza). While fever is common with the flu and COVID-19, sneezing is typically only associated with colds. Though sore throats are typical with colds, they are uncommon with COVID-19 infections and the flu.
COVID-19 (Coronavirus, 2019-nCoV)
Infection with COVID-19 (2019 novel coronavirus, 2019-nCoV) causes respiratory problems in humans. Transmission of COVID-19 occurs mainly through contact with respiratory sections from an infected person, however, fecal contamination may also spread the virus. Symptoms start off flu-like and progress to coughing, fever, shortness of breath, shaking chills, headache, loss of sense of taste and/or smell, muscle pain, and sore throat. Treatment focuses on supportive care and symptom relief. COVID-19 vaccines are available.
Is Your Immune System Stronger After COVID-19?
A robust immune system protects you from getting sick following exposure to germs and viruses. Yes, recovering from COVID-19 makes your immune system stronger.
How Long Is a COVID-19 Patient Contagious?
People infected with COVID-19 can still be contagious even when they stop feeling sick, so precautionary measures should continue for at least 2 weeks after symptoms disappear and until the COVID-19 test result is negative. Ideally, patients should be quarantined at home or an institution for 2 weeks after the symptoms completely disappear.
Can Diarrhea Be an Initial Symptom of COVID-19?
COVID-19 has become a common illness that affects many people. Learn the signs of COVID-19, what causes it, how doctors diagnose it, and what you can do to treat it.
COVID-19 vs. Allergies
Though there is some overlap in allergy and COVID-19 signs and symptoms there are also significant differences. Symptoms that they have in common include headache, fatigue, tiredness, shortness of breath, wheezing, and sore throat. Fever does not occur with allergies but is one of the defining symptoms of COVID-19 infections.
How Soon After the COVID-19 Booster Vaccines Are You Protected?
According to recent studies, it takes about 14 days after receiving the COVID-19 booster vaccine for your immune system to offer protection from the virus.
COVID-19 (Coronavirus) Prevention Tips
COVID-19 is a novel coronavirus that spreads from person to person via infected respiratory droplets. The main symptoms of COVID-19 infection include cough, fever, and shortness of breath. Occasionally, people infected with COVID-19 may experience diarrhea, a sore throat, a runny or stuffy nose, or aches and pains. Avoiding contact with infected people, social distancing, not touching your face, frequent hand washing, cleaning, and disinfecting of frequently touched surfaces can help to reduce your risk of contracting the 2019 novel coronavirus.
How Long Does Immunity Last After You Get Moderna, Pfizer, or Johnson & Johnson COVID-19 Vaccines?
People's bodies all respond differently to the vaccines so to understand how long immunity lasts, it comes down to your body’s antibody production.
Does COVID-19 Affect My Heart?
As per the American Heart Association, COVID-19 may have a long-term effect on the heart. Having a heart condition doesn't make a person more likely to catch COVID-19, but an individual with heart disease or a serious heart condition is more likely to become severely ill from COVID-19 and has a higher risk of death.
Which Type of Diabetes Is Worse for COVID?
COVID-19, the disease caused by the SARS-CoV-2 virus, is a mild illness in most people. People with type 1 diabetes have 3.5 times the risk of dying compared to people without diabetes and people with type 2 diabetes have double the mortality risk with this viral infection.
Can You Get the COVID-19 Vaccine If You’re Pregnant?
The answer is 'Yes, you can get the COVID-19 vaccine if you’re pregnant.' But you may want to talk to your doctor before you get the vaccine.
Treatment & Diagnosis
- Wuhan Coronavirus FAQs
- Coronavirus COVID-19 Prevention FAQs
- COVID-19 Vaccine Myths and Facts FAQs
- What if I get COVID-19 with Rheumatoid Arthritis?
- What Are Monoclonal Antibody Treatments for COVID-19 Coronavirus?
- Testing Is Key to COVID-19 Recovery for Patients and Economy
- Should I Go to the Dentist During the COVID-19 Pandemic?
- Is the Test for COVID-19 Coronavirus Reliable?
- How Long Can the COVID-19 Coronavirus Survive?
- What if I get COVID-19 with Diabetes?
- What if I Get COVID-19 with Asthma?
Medications & Supplements
Prevention & Wellness
- Add COVID Shot to Routine Vaccine Schedule: CDC Panel
- Canada May Soon Drop COVID Vaccine Requirement for International Travelers
- Administration May Stop Buying COVID Vaccines, Treatments by Fall
- U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
- FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
- FDA Backs Pfizer, Moderna for Kids 5 and Under
- FDA Panel to Decide on Novavax COVID Vaccine
- Vaccines Don't Shield Against Long COVID, But May Ease Symptoms
- 3-Dose Pfizer COVID Vaccine Spurs Strong Response in Youngest Kids
- CDC Advisers Recommend Pfizer Booster Shot for Kids Ages 5 to 11
- FDA Authorizes Pfizer Booster Shot for Kids Ages 5 to 11
- Company Hid Problems With COVID Vaccines From FDA
- U.S. Extends COVID Vaccination Rule for International Travelers at Land Borders
- AHA News: Future of COVID-19 Vaccines Brings High Hopes, Familiar Obstacles
- Does the Moderna Vaccine Best the Pfizer Shot?
- Vaccination Mandate for Federal Workers Reinstated by Appeals Court
- FDA Advisors Weigh COVID Booster Shots for Fall
- Had COVID? Getting Vaccine Boosts Resilience Even More, Studies Show
- Vaccinated More Likely to Die During Omicron Wave If They Got J&J Shot: CDC
- Pfizer Asks FDA to Approve Second Booster for Seniors
- About 1 in 6 U.S. Couples Disagrees on COVID Vaccination
- Biden Unveils New 'Test to Treat' Plan as Key Part of New COVID Strategy
- Pfizer Vaccine Much Less Potent in Kids Aged 5 to 11
- One Big Motivator to Get COVID Vaccine: Travel
- Allergic Reaction to Your First COVID Shot? Risk of Another Is Low
- Is the Next Great COVID Vaccine an Inhaled One?
- FDA Postpones Pfizer COVID Vaccine for Kids Under 5
- Pfizer Seeks Approval for COVID Vaccine for Kids Under 5
- Beyond Antibodies: Vaccines Teach T-Cells to Fight COVID Long Term
- Study Finds Delta Somewhat Resistant to Vaccines — What About Omicron?
- Pfizer COVID Antiviral Pill Goes to FDA for Approval
- Federal Court Backs Stay on COVID Vaccine Mandate
- Pfizer Seeks Booster Approval for 18 and Up
- What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-Olds
- Lower Dose of Pfizer COVID Vaccine Protects Younger Children, Company Says
- FDA Weighs Moderna, J&J Booster Shot Approval
- FDA Approval Sought for First COVID Antiviral Pill
- CDC Endorses Booster Shots for Millions of Americans
- FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
- Lower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company Says
- COVID Death 11x More Likely for Unvaccinated
- White House Issues Tough New Vaccine Mandates
- White House Pushes for More Vaccine Mandates
- COVID-19 Vaccines Boost Antibodies, Even in People With Weak Immune Systems
- Vaccine Power Against COVID Hospitalization Fades in Elderly
- 'Dream Vaccine' for All COVID Variants
- COVID Booster Shots at 8 Months
- COVID Booster Shots Could Come by Fall
- FDA to OK COVID Booster Shots for Vulnerable Americans
- COVID Vaccination Required for Most Foreign Visitors to US
- U.S. Reaches 70 Percent Vaccination Milestone
- New Data Shows the Power of COVID Vaccines
- 3rd Shot of COVID Vaccine Boosts Protection, Pfizer Says
- J&J Vaccine Weak Against Delta Variant, 2nd Dose May Be Needed
- CDC Advisors to Discuss 3rd COVID Vaccine Dose for Immunocompromised
- Vaccine Effectiveness and Third COVID Booster Shot
- Will We Need a COVID Booster Shot?
- As COVID Vaccination Rates Climb in U.S., COVID Deaths Drop
- Low COVID Vaccination Rates for Seniors in 11 States a 'Powder Keg'
- Will We Need a Yearly COVID Booster Vaccine?
- The Real-World Power of Pfizer, Moderna COVID Vaccines
- 'Mix & Match' COVID Vaccine Approach in Testing
- FDA Approves COVID Vaccine for Ages 12 to 15
- U.S. COVID Outlook Shows Improvement by July
- Millions Have Missed Second COVID Vaccine Shot
- COVID-19 Vaccine: When Supply Outstrips Demand
- All Adults Now Eligible for COVID-19 Vaccine in US
- What's the Best COVID Vaccine?
- Second Dose of COVID Vaccine Is Likely to Feel Worse
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.